Clinical features, diagnosis, and treatment of diabetic neuropathy;Klinik, Diagnostik und Therapie der diabetischen Neuropathie

Therapeutische Umschau

Volumn 53, Issue 12, 1996, Pages 948-957

  Ziegler, D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; CARBAMAZEPINE; CISAPRIDE; CLONIDINE; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROPOIETIN; FLUDROCORTISONE; IMIPRAMINE; METOCLOPRAMIDE; MEXILETINE; MIDODRINE; PRAZOSIN; PROSTAGLANDIN E1; PROSTAVASIN; RECOMBINANT ERYTHROPOIETIN; THIOCTIC ACID;

BLADDER DYSFUNCTION; DIABETIC NEUROPATHY; DIARRHEA; HUMAN; HYPOTENSION; IMPOTENCE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PROGNOSIS; SHORT SURVEY; STOMACH PARESIS; TOPICAL DRUG ADMINISTRATION;

AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DIABETES MELLITUS; DIABETIC NEUROPATHIES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; NEUROLOGIC EXAMINATION; PERIPHERAL NERVOUS SYSTEM DISEASES; RISK FACTORS;

EID: 0030457472     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. Diab. Care 11, 592-597, 1988.
2. Ziegler D., Gries F. A.: Klinik, Pathogenese und Therapie der diabetischen Neuropathie. Akt. Endokrin. Stoffw. 13, 140-150, 1992.
3. Ziegler D.: Diagnosis, staging and epidemiology of diabetic peripheral neuropathy. Diab. Nutr. Metab. 7, 342-348, 1994.
4. Ziegler D., Gries F. A.: Diagnostik und Therapie der kardiovaskulären autonomen diabetischen Neuropathie. Diab. Stoffw. 3, 22-31, 1994.
5. Thomas P. K., Eliasson S. G.: Diabetic neuropathy. In: Peripheral neuropathy, Dyck P. J., Thomas P. K., Lambert E. H., Bunge R. [eds]. Saunders Philadelphia, 1773-1810, 1986.
6. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. Diab. Care 15 [Suppl. 3], 1095-1103, 1992.
7. Ziegler D.: Diabetic cardiovascular autonomic neuropathy. Prognosis, diagnosis, and treatment. Diabetes/Metab. Rev. 10, 339-383, 1994.
8. Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association. Neurology 43, 1050-1052, 1993.
9. Rathmann W., Ziegler D.: Aktuelle Aspekte zur Pathogenese, Diagnostik und Therapie der diabetisehen Gastroparese. Diab. Stoffw. 3, 417-421, 1991.
10. Greene D. A., Sima A. A. F., Albers J. W., Pfeifer M. A.: Diabetic Neuropathy. In: Diabetes mellitus, Rifkin H., Porte D. [eds.]. Elsevier. New York, 710-755, 1990.
11. Cameron N. E., Cotter M. A.: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diab./Metab. Rev. 10, 189-224, 1994.
12. Ziegler D., Hanefeld M., Ruhnau K. J., Meißner H. P., Lobisch M., Schütte K., Nehrdich D., Dannehl K., Gries F. A.: The ALADIN Study Group. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Studyl. Diabetologia 38, 1425-1433, 1995.
13. Ziegler D., Conrad F., Ulrich H., Reichel G., Schatz H., Gries F. A.: Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial [DEKAN Study]. Diabetes Care 20, 1997 [im Druck].
14. Thomas P. K.: Painful diabetic neuropathy. Mechanisms and treatment. Diab. Nutr. Metab. 7, 359-368, 1994.
15. Sindrup S. H.: Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects. Dan. med. Bull. 41, 66-78, 1994.
16. Stracke H., Meyer U. E., Schumacher H. E., Federlin K.: Mexiletine in the treatment of diabetic neuropathy. Diab. Care 15, 1550-1555, 1992.
17. Linet O. I., Ogrinc F. G.: Alprostadil Study Group. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New Engl. J. Med. 334, 873-877, 1996.